{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:45:00Z","timestamp":1793922300568,"version":"4.8.0"},"reference-count":49,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.3201\/eid2811.220415","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T09:55:31Z","timestamp":1666778131000},"page":"1-8","source":"Crossref","is-referenced-by-count":106,"title":["Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic"],"prefix":"10.3201","volume":"28","author":[{"given":"Genara Romero","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Paster\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Shal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Pillonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Tigulini","family":"de Souza Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hormaz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Yamile","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1 Victoria","family":"Ovalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Antonieta","family":"Jim\u00e9nez Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grettel Chanto","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Carbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Julia","family":"Mazariegos Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene del Carmen Gonz\u00e1lez","family":"Vel\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Satan-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Melgarejo","family":"Touchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Busignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Mayta-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ram\u00edrez-Illescas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana L\u00f3pez","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mogdasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuris","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"El-Omeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Fabi\u00e1n","family":"Galas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ram\u00f3n-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Gustavo","family":"Melano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2811.220415-202210241431-R1","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cmi.2021.06.001","article-title":"The interface between COVID-19 and bacterial healthcare-associated infections.","volume":"27","author":"O\u2019Toole","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2811.220415-202210241431-R2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing.","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R3","doi-asserted-by":"publisher","first-page":"FSO736","DOI":"10.2144\/fsoa-2021-0012","article-title":"The COVID-19 pandemic: a threat to antimicrobial resistance containment.","volume":"7","author":"Founou","year":"2021","journal-title":"Future Sci OA"},{"key":"key-10.3201\/eid2811.220415-202210241431-R4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J Infect Public Health"},{"key":"key-10.3201\/eid2811.220415-202210241431-R5","doi-asserted-by":"publisher","first-page":"e64139","DOI":"10.7554\/eLife.64139","article-title":"Antimicrobial resistance and COVID-19: Intersections and implications.","volume":"10","author":"Knight","year":"2021","journal-title":"eLife"},{"key":"key-10.3201\/eid2811.220415-202210241431-R6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijid.2020.12.087","article-title":"Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.","volume":"104","author":"Lucien","year":"2021","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/ice.2021.362","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network.","volume":"43","author":"Weiner-Lastinger","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2811.220415-202210241431-R8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.","volume":"30","author":"Gasink","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2811.220415-202210241431-R9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2012.10.028","article-title":"Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?","volume":"66","author":"Vardakas","year":"2013","journal-title":"J Infect"},{"key":"key-10.3201\/eid2811.220415-202210241431-R10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/14656566.2021.1904891","article-title":"Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases.","volume":"22","author":"Lynch","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.3201\/eid2811.220415-202210241431-R11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases.","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2811.220415-202210241431-R12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/CMR.00116-14","article-title":"The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.","volume":"28","author":"Mathers","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2811.220415-202210241431-R13","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace.","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jhin.2016.10.006","article-title":"Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.","volume":"95","author":"French","year":"2017","journal-title":"J Hosp Infect"},{"key":"key-10.3201\/eid2811.220415-202210241431-R15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-producing organisms: a global scourge.","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13756-019-0630-3","article-title":"Genomic characterization of Citrobacter freundii strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in Spain.","volume":"8","author":"Lalaoui","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"key-10.3201\/eid2811.220415-202210241431-R17","doi-asserted-by":"publisher","first-page":"104479","DOI":"10.1016\/j.meegid.2020.104479","article-title":"Co-occurrence of a novel VIM-1 and FosA3-encoding multidrug-resistant plasmid and a KPC-2-encoding pKP048-like plasmid in a clinical isolate of Klebsiella pneumoniae sequence type 11.","volume":"85","author":"Tang","year":"2020","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2811.220415-202210241431-R18","unstructured":"Pan American Health Organization\/World Health Organization. Magnitude and trends of antimicrobial resistance in Latin America. ReLAVRA 2014, 2015, 2016. Summary Report. 2020 Oct 16 [cited 2022 Aug 25]. https:\/\/www.paho.org\/en\/documents\/magnitude-and-trends-antimicrobial-resistance-latin-america-relavra-2014-2015-2016"},{"key":"key-10.3201\/eid2811.220415-202210241431-R19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14787210.2017.1268918","article-title":"The epidemiology of carbapenemases in Latin America and the Caribbean.","volume":"15","author":"Escand\u00f3n-Vargas","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.3201\/eid2811.220415-202210241431-R20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","article-title":"Update on the epidemiology of carbapenemases in Latin America and the Caribbean.","volume":"19","author":"Garc\u00eda-Betancur","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.3201\/eid2811.220415-202210241431-R21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R22","unstructured":"Pan American Health Organization \/ World Health Organization. Epidemiological alert: emergence and increase of new combinations of carbapenemases in Enterobacterales in Latin America and the Caribbean. 2021 Oct 22 [cited 2022 Aug 25]. https:\/\/www.paho.org\/en\/documents\/epidemiological-alert-emergence-and-increase-new-combinations-carbapenemases"},{"key":"key-10.3201\/eid2811.220415-202210241431-R23","unstructured":"Ministry of Health of Argentina. Antimicrobial Agents Service, INEI ANLIS \u201cDr. Carlos G. Malbr\u00e1n\u201d. Epidemiological alert: emergency of Enterobacterales double producers of carbapenemases [in Spanish]. Newsletter No 4. 2021 Apr [cited 2022 Aug 25]. http:\/\/antimicrobianos.com.ar\/2021\/04\/alerta-epidemiologica-enterobacterales-doble-productores-de-carbapenemasas"},{"key":"key-10.3201\/eid2811.220415-202210241431-R24","unstructured":"Ministry of Public Health and Social Assistance of Guatemala. Epidemiology department. Circular 12\u201320. Epidemiological alert for the first finding of OXA-48 type carbapenemase in Guatemala [in Spanish]. 2020 Dec 8 [cited 2022 Aug 25]. http:\/\/portal.lns.gob.gt\/media\/attachments\/2021\/09\/14\/circular-17-2020-alerta-carbapenemasas-oxa-48.pdf"},{"key":"key-10.3201\/eid2811.220415-202210241431-R25","unstructured":"Ministry of Public Health and Social Assistance of Guatemala. Epidemiology department. Circular Jefatura No. TLGG-27\u20132021. Alert update due to the appearance of isolates producing OXA-48 like carbapenemases [in Spanish]. 2021 Jul 1 [cited 2022 Aug 25]. http:\/\/portal.lns.gob.gt\/media\/attachments\/2021\/09\/14\/circular-no.-27-alerta-cabapenemasa-oxa-1.pdf"},{"key":"key-10.3201\/eid2811.220415-202210241431-R26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18004\/mem.iics\/1812-9528\/2021.019.03.35","article-title":"First report of double carbapenemases-producing Enterobacterales in hospitals of Paraguay","volume":"19","author":"Melgarejo Touchet","year":"2021","journal-title":"Mem Inst Investig Cienc Salud."},{"key":"key-10.3201\/eid2811.220415-202210241431-R27","unstructured":"Ministry of Health of Brazil. Brazilian Health Regulatory Agency (ANVISA). Technical Note GVIMS\/GGTES\/ANVISA N\u00ba 05\/2021. Guidelines for the prevention and control of the dissemination of multidrug-resistant microorganisms in health services in the context of the COVID-19 pandemic [in Portuguese]. 2021 Aug [cited 2022 Aug 25]. https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/servicosdesaude\/notas-tecnicas\/nota-tecnica-gvims-ggtes-anvisa-no-05-2021-resistencia-microbiana-na-pandemia-da-covid-19\/view"},{"key":"key-10.3201\/eid2811.220415-202210241431-R28","unstructured":"The European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net)\u2014annual epidemiological report for 2019 [cited 2021 Aug 12]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019"},{"key":"key-10.3201\/eid2811.220415-202210241431-R29","unstructured":"Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, Antibiotic Resistance Coordination and Strategy Unit. Antibiotic resistance threats in the United States, 2019. Atlanta; The Centers; 2019 [cited 2022 Aug 25]. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"key":"key-10.3201\/eid2811.220415-202210241431-R30","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: The Review on Antimicrobial Resistance, 2016 [cited 2022 Aug 25]. https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf"},{"key":"key-10.3201\/eid2811.220415-202210241431-R31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"key-10.3201\/eid2811.220415-202210241431-R32","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/jac\/dkab300","article-title":"Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.","volume":"76","author":"Tomczyk","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2811.220415-202210241431-R33","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"key-10.3201\/eid2811.220415-202210241431-R34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R35","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1128\/IAI.00298-15","article-title":"Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease.","volume":"83","author":"Rynda-Apple","year":"2015","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2811.220415-202210241431-R36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"key-10.3201\/eid2811.220415-202210241431-R37","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics.","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid2811.220415-202210241431-R38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/antibiotics10060745","article-title":"Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: a scoping review.","volume":"10","author":"Cong","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"key-10.3201\/eid2811.220415-202210241431-R39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2811.220415-202210241431-R40","unstructured":"The Pew Charitable Trusts. Antibiotic Resistance Project. Could efforts to fight the coronavirus lead to overuse of antibiotics? 2021 Mar 10 [cited 2022 Aug 25]. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/issue-briefs\/2021\/03\/could-efforts-to-fight-the-coronavirus-lead-to-overuse-of-antibiotics"},{"key":"key-10.3201\/eid2811.220415-202210241431-R41","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/apa.15847","article-title":"High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: A multinational experience in 990 cases from Latin America.","volume":"110","author":"Yock-Corrales","year":"2021","journal-title":"Acta Paediatr"},{"key":"key-10.3201\/eid2811.220415-202210241431-R42","doi-asserted-by":"publisher","first-page":"778386","DOI":"10.3389\/fphar.2021.778386","article-title":"Increased use of antibiotics in the intensive care unit during coronavirus disease (COVID19) pandemic in a Brazilian hospital.","volume":"12","author":"Silva","year":"2021","journal-title":"Front Pharmacol"},{"key":"key-10.3201\/eid2811.220415-202210241431-R43","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"key-10.3201\/eid2811.220415-202210241431-R44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijid.2019.06.016","article-title":"One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America.","volume":"86","author":"Huerta-Guti\u00e9rrez","year":"2019","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jac\/dkab459","article-title":"Point prevalence survey of antibiotic use in hospitals in Latin American countries.","volume":"77","author":"Levy Hara","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2811.220415-202210241431-R46","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/cid\/ciab612","article-title":"Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.","volume":"74","author":"Outterson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2811.220415-202210241431-R47","first-page":"e42","article-title":"[Evolution of the performance of Latin America Reference Laboratories in the detection of mechanisms of antimicrobial resistanceEvolu\u00e7\u00e3o do desempenho dos Laborat\u00f3rios de Refer\u00eancia na Am\u00e9rica Latina na detec\u00e7\u00e3o de mecanismos de resist\u00eancia antimicrobiana]","volume":"44","author":"Gagetti","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"key-10.3201\/eid2811.220415-202210241431-R48","first-page":"e65","article-title":"[Latin American consensus to define, categorize, and report multidrug-resistant, extensively drug-resistant, or pandrug-resistant pathogensConsenso latino-americano para defini\u00e7\u00e3o, categoriza\u00e7\u00e3o e notifica\u00e7\u00e3o de pat\u00f3genos multirresistentes, com resist\u00eancia ampliada ou panresistentes]","volume":"43","author":"Jim\u00e9nez Pearson","year":"2019","journal-title":"Rev Panam Salud Publica"},{"key":"key-10.3201\/eid2811.220415-202210241431-R49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jac\/dkab426","article-title":"BSAC Vanguard Series: Inequality and antibiotic resistance.","volume":"77","author":"Mendelson","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/11\/22-0415_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:53:59Z","timestamp":1732971239000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/11\/22-0415_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2811.220415","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}